TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +0.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement XLO
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – +589.9%
– +343.8% +40.8% +23.2% +2.9% -13.5% -6.3%
– – – – – – +565.6%
– +208.0% +16.6% +15.7% -11.9% -21.0% +36.0%
– +123.3% +123.9% +25.5% -9.9% -8.2% +19.9%
– +184.8% +40.3% +18.8% -11.2% -15.4% +25.8%
– – – – – – –
– – +26.0% +22.6% -86.2% -21.8% –
– – – – – – –
– +1,160.2% -274.6% – – – –
– – – – – – –
– – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?